Einblicke 22.01.20222021 has been a fast-moving year with unprecedented milestones for … 2021 has been a fast-moving year with unprecedented milestones for Nice & Green. Find out more in our „Year In Review“.Mehr erfahren
Finanzierung 27.12.2021Nice & Green, the Swiss investment firm, commits to additional … Nice & Green extends its support to the Swiss biotech Evolva with additional financing of CHF 12MMehr erfahren
Finanzierung 28.06.2023Nice & Green, the Swiss investment firm, announces today the … Nice & Green provides Endurance Motive with EUR 2.4 million in funding to support its development and growth projectsMehr erfahren
Einblicke 28.06.2023Nice & Green, the Swiss investment firm, announces today its … Nice & Green participates in the IPO of the French biotech MaaT Pharma now listed on Euronext ParisMehr erfahren
Finanzierung 28.06.2023Nice & Green, the Swiss investment firm, announced today the … Nice & Green enters a 4-year investment partnership with EEMS Italia SpA which will consolidate its presence in the Energy Transition market by 2026Mehr erfahren
